LYKALABSNSELyka Labs Limited· PharmaceuticalsHighNeutral
Announced Fri, 8 Aug · 17:40 IST

Lyka Labs Limited has informed the Exchange about General Updates

Nclt Scheme FiledStrategic Transactions View source PDF

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Lyka Labs Limited informed the exchanges that the NCLT Ahmedabad Bench heard the Scheme of Amalgamation between Lyka Exports Limited (Transferor) and Lyka Labs Limited (Transferee) on 7th August 2025. The Regional Director and Income Tax Department submitted their replies with no objection to the scheme. The NCLT has reserved its order for formal pronouncement. This follows an earlier rejection of a prior petition, with the company now having refiled and completed all compliances. A formal disclosure will follow once the NCLT order is officially pronounced.

Likely market impact

The scheme is one step closer to approval, with no objections from regulatory bodies. If approved, Lyka Exports Limited will merge into Lyka Labs, which could simplify the group's structure. Shareholders should watch for the formal NCLT order and any subsequent share-swap ratio announcement.